- Home
- BMY
as 09-06-2024 4:00pm EST
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
| Founded: | 1887 | Country: | United States |
| Employees: | N/A | City: | PRINCETON |
| Market Cap: | 95.4B | IPO Year: | N/A |
| Target Price: | $56.50 | AVG Volume (30 days): | 10.2M |
| Analyst Decision: | Hold | Number of Analysts: | 17 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | -3.22 | EPS Growth: | N/A |
| 52 Week Low/High: | $39.35 - $61.43 | Next Earning Date: | 10-24-2024 |
| Revenue: | $46,509,000,000 | Revenue Growth: | 2.93% |
| Revenue Growth (this year): | 5.04% | Revenue Growth (next year): | -0.13% |
Latest Bristol-Myers Squibb Company News
BMY Breaking Stock News: Dive into BMY Ticker-Specific Updates for Smart Investing
Zacks
a day ago
Implied Volatility Surging for Bristol-Myers (BMY) Stock Options
Zacks
a day ago
Argenx (ARGX) Moves 4.0% Higher: Will This Strength Last?
Business Wire
2 days ago
Bristol Myers Squibb Employees to Relay Nearly 3,000 Miles Cross-Country Aspiring to Raise Over $1 Million for the V Foundation for Cancer Research
Zacks
2 days ago
Bristol Myers Squibb (BMY) Falls More Steeply Than Broader Market: What Investors Need to Know
Insider Monkey
2 days ago
Is Bristol-Myers Squibb Company (BMY) The Best Beaten Down Dividend Stocks to Invest in Now?
Zacks
3 days ago
Why Is Axsome (AXSM) Up 4.8% Since Last Earnings Report?
Reuters
5 days ago
US will still pay at least twice as much after negotiating drug prices
Motley Fool
5 days ago
2 Reasons Bristol Myers Squibb Stock Could Be a Bargain, Down 34% From Its All-Time High
Compare BMY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BMY Bristol-Myers Squibb Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.